| Christopher W Hauge, MD | |
|
3907 Creekside Loop, Suite 130, Yakima, WA 98902-4879 | |
| (509) 225-4555 | |
| (509) 225-4554 |
| Full Name | Christopher W Hauge |
|---|---|
| Gender | Male |
| Speciality | Surgery - Plastic And Reconstructive Surgery |
| Location | 3907 Creekside Loop, Yakima, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790792265 | NPI | - | NPPES |
| 1108943 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0122X | Surgery - Plastic And Reconstructive Surgery | MD00013415 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Christopher W Hauge, MD 3907 Creekside Loop, Suite 130, Yakima, WA 98902-4879 Ph: (509) 225-4555 | Christopher W Hauge, MD 3907 Creekside Loop, Suite 130, Yakima, WA 98902-4879 Ph: (509) 225-4555 |
News Archive
Research led by the Translational Genomics Group at Vall d'Hebron Institute of Oncology (VHIO) in Barcelona has not only shown that HER2+ breast cancer can be classified into four different subtypes, but also unmasked a subtype showing both a greater response to and increased benefit from chemotherapy and anti-HER2 therapy.
Various types of information can be ascertained by the way blood flows through the brain. When a region of the brain has been activated, blood flow increases and oxygenation rises. By observing variations in blood flow with the help of non-invasive imaging, it is possible to determine which regions are at work at a given point in time and how they work together.
Titan Spine, a medical device surface technology company focused on the development of innovative spinal interbody fusion implants, announced today that it has been awarded patent #US 8,262,737 B2 by the United States Patent Office that protects the Company against competitive interbody devices with a roughened surface topography, anti-expulsion edges, and access to a hollow center.
In a major advance in treatment, a multicenter study found that ruxolinitib did a better job than off-label chemotherapy drugs reducing the terrible symptoms associated with myelofibrosis, including pain, enlarged spleen, anemia, fever, chills, fatigue, and weight loss.
› Verified 5 days ago
Katherine Irene Warner, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 1607 Creekside Loop, Yakima, WA 98902 Phone: 509-453-4614 Fax: 509-225-2712 | |
Justin A Robinson, MD Surgery Medicare: Medicare Enrolled Practice Location: 3999 Englewood Ave, Suite 202, Yakima, WA 98902 Phone: 509-453-4614 Fax: 509-453-3468 | |
Lorena P De Marco Garcia, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1607 Creekside Loop, Suite 100, Yakima, WA 98902 Phone: 509-453-4614 Fax: 509-225-2712 | |
Jihui Li, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 3003 Tieton Dr Ste 300, Yakima, WA 98902 Phone: 509-575-3946 | |
Dr. Peter R Young Jr., M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 3003 Tieton Dr, Suite 300, Yakima, WA 98902 Phone: 509-575-3946 Fax: 509-225-6449 | |
Dr. Amber Nicole Wooten, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 3003 Tieton Dr Ste 300, Yakima, WA 98902 Phone: 509-575-3946 Fax: 509-225-2701 | |
Lester Shinchen Young, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2811 Tieton Dr, Yakima, WA 98902 Phone: 509-575-3946 |